Steady state study for Carbamazepine [Study Per­for­mance]

posted by labanya – 2009-02-27 14:28 (6322 d 22:20 ago) – Posting: # 3296
Views: 7,501

Hi,

We are planning to conduct a steady state BE study for carbamazepine extended release tablet of the highest dose. I would like to know:
First will the metabolite be analysed in this case?
Second if any tablet gets missed or the subject vomits after dosing then will the subject be withdrwan from the study?

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
125 visitors (0 registered, 125 guests [including 18 identified bots]).
Forum time: 13:49 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5